Biomedical Systems, Center for Diagnostic Imaging partner

Biomedical Systems has partnered with the Center for Diagnostic Imaging (CDI) to provide pharmaceutical companies, biotechnology companies and contract research organizations a single-source option for clinical research requiring the use of imaging technology and analysis.
   
Biomedical Systems Centralized Imaging Services is dedicated to the execution of centralized imaging data acquisition, analysis, and management for pharmaceutical clinical trials Phase I-IV. Biomedical Systems can acquire and process data in a multitude of modalities including: MRI, PET, angiography, echocardiography, x-ray, nuclear, and CT. The company's Pharmaceutical Division offers the option of combining multiple centralized diagnostic core lab services under one umbrella for study protocols that have an additional need for ECGs, holter, spirometry, and ambulatory blood pressure monitoring.
   
CDI's 32 facilities can be used as either primary or additional investigative sites by sponsors for clinical studies. CDI will provide access to more than 100 radiologists trained in a number of disciplines that can serve as blinded readers, expert consultants or as investigators.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup